Effect of cholesterol on the properties of spray-dried lysozyme-loaded liposomal powders

AAPS PharmSciTech

Volumn 11, Issue 2, 2010, Pages 832-842

  Charnvanich, Dusadee ^a   Vardhanabhuti, Nontima ^a   Kulvanich, Poj ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Cholesterol; Liposomes; Lysozyme; Spray dried powders

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; CHOLESTEROL; HEPES BUFFERED SALINE; LIPOSOME; LYSOZYME; MANNITOL; MISCELLANEOUS DRUGS AND AGENTS; PEPTIDE; PHOSPHATIDYLCHOLINE; PROTEIN; UNCLASSIFIED DRUG; DRUG CARRIER; EXCIPIENT; GAS; POWDER;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENZYME RECONSTITUTION; HYDROGENATION; LIPOSOMAL DELIVERY; LUNG ALVEOLUS; MOLECULAR MODEL; PARTICLE SIZE; PHYSICAL CHEMISTRY; POWDER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; TEMPERATURE DEPENDENCE; THERMAL ANALYSIS; X RAY DIFFRACTION; ABSORPTION; CHEMISTRY; ENZYME STABILITY; GAS; METABOLISM; MICROCOCCUS; PROCEDURES;

ABSORPTION; CHOLESTEROL; DRUG CARRIERS; DRUG COMPOUNDING; ENZYME STABILITY; EXCIPIENTS; GASES; LIPOSOMES; MICROCOCCUS; MURAMIDASE; POWDERS;

EID: 77954817644     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9442-8     Document Type: Article

References (44)

1. Zeng XM, Martin GP, Marriott C. The controlled drug delivery to the lung. Int J Pharm. 1995;124:149-64. doi:10.1016/0378-5173 (95) 00104-Q.
2. Huang Y.-Y., Wang C.-H. Pulmonary delivery of insulin by liposomal carriers. J Control Release. 2006;113:9-14. doi:10.1016/j. jconrel.2006.03.014.
3. Briscoe P, Caniggia I, Graves A, Benson B, Huang L, Tanswell AK et al. Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. Am J Physiol. 1995;268: L374-80.
4. Schreier H, Gonazales-Rothi RJ, Stecenko AA. Pulmonary delivery of liposomes. J Control Release. 1992;24:209-23. doi:10.1016/0168-3659 (93) 90180-D.
5. Zaru M, Mourtas S, Klepetsanis P, Fadda AM, Antimisiaris SG. Liposomes for drug delivery to the lungs by nebulization. Eur J Pharm Biopharm. 2007;67:655-66. doi:10.1016/j.ejpb.2007.04.005. (Pubitemid 47576612)
6. Niven RW, Carvajal MA, Schreier H. Nebulization of liposomes. III. The effects of operating conditions and local environment. Pharm Res. 1992;9:515-20. doi:10.1023/A:1015844430695.
7. Prime D, Atkins PJ, Slater A, Sumby B. Review of dry powder inhalers. Adv Drug Deliv Rev. 1997;26:51-8. doi:10.1016/S0169-409X (97) 00510-3.
8. Kim C.-K., Chung H.-S., Lee M.-K., Choi L.-N., Kim M.-H. Development of dried liposomes containing β-galactosidase for the digestion of lactose in milk. Int J Pharm. 1999;183:185-93. doi:10.1016/S0378-5173 (99) 00115-5.
9. Lo Y, Tsai J, Kuo J. Liposomes and disaccharides as carriers in spray-dried powder formulations of superoxide dismutase. J Control Release. 2004;94:259-72. doi:10.1016/j.jconrel.2003.09.019. (Pubitemid 38117138)
10. Kellaway IW, Farr SJ. Liposomes as drug delivery systems to the lung. Adv Drug Deliv Rev. 1990;5:149-61. doi:10.1016/0169-409X (90) 90012-H.
11. Cryan S.-A. Carrier-based strategies for targeting protein and peptide drugs to the lungs. AAPS J. 2005;7(1):E20-40. doi:10.1208/aapsj070104. (Pubitemid 41554302)
12. Shoyele SA, Cawthorne S. Particle engineering techniques for inhaled biopharmaceuticals. Adv Drug Deliv Rev. 2006;58:1009-29. doi:10.1016/j.addr. 2006.07.010. (Pubitemid 44712022)
13. Kikuchi H, Yamauchi H, Hirota S. A spray-drying method for mass production of liposomes. Chem Pharm Bull. 1991;39:1522-7.
14. Goldbach P, Brochart H, Stamm A. Spray-drying of liposomes for a pulmonary administration. II. Retention of encapsulated materials. Drug Dev Ind Pharm. 1993;19:2623-36. doi:10.3109/03639049309047205. (Pubitemid 23337908)
15. Grenha A, Remunan-Lopez C, Carvalho E L S, Seijo B. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. Eur J Pharm Biopharm. 2008;69:83-93. doi:10.1016/j.ejpb. 2007.10.017.
16. Chougule MB, Padhi BK, Misra A. Development of spray dried liposomal dry powder inhaler of dapsone. AAPS PharmSciTech. 2008;9(1):47-53. doi:10.1208/s12249-007-9024-6.
17. Skalko-Basnet N, Pavelic Z, Becirevic-Lacan M. Liposomes containing drug and cyclodextrin prepared by the one-step spray-drying method. Drug Dev Ind Pharm. 2000;26(12):1279-84. doi:10.1081/DDC-100102309. (Pubitemid 32037424)
18. Weers JG, Tarara TE, Tzannis S. Lipid formulations for spontaneous drug encapsulation. US patent application 20050214224, 4 Nov. 2004.
19. Desai TR, Wong JP, Hancock R E W, Finlay WH. A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling. J Pharm Sci. 2002;91:482-91. doi:10.1002/jps.10021. (Pubitemid 34137369)
20. Coderch L, Fonollosa J, Pera MD, Estelrich J, Maza A D L, Parra JL. Influence of cholesterol on liposome fluidity by EPR relationship with percutaneous absorption. J Control Release. 2000;68:85-95. doi:10.1016/S0168- 3659 (00) 00240-6. (Pubitemid 30407064)
21. McMullen T P W, Lewis R N A H, McElhaney RN. Differential scanning calorimetric study of the effect of cholesterol on the thermotropic phase behavior of a homologous series of linear saturated phosphatidylcholines. Biochemistry. 1993;32:516-22. doi:10.1021/bi00053a016. (Pubitemid 23034888)
22. Ohtake S, Schebor C, Palecek SP, de Pablo JJ. Phase behavior of freeze-dried phospholipid-cholesterol mixtures stabilized with trehalose. Biochim Biophys Acta. 2005;1713:57-64. doi:10.1016/j. bbamem.2005.05.001.
23. Popova AV, Hincha DK. Effects of cholesterol on dry bilayers: interactions between phosphatidylcholine unsaturation and glycolipid or free sugar. Biophys J. 2007;93:1204-14. doi:10.1529/biophysj.107.108886. (Pubitemid 47330900)
24. Rosenberger F. Protein crystallization. J Cryst Growth. 1996;166:40-54. doi:10.1016/0022-0248 (95) 00921-3.
25. Steckel H, Bolzen N. Alternative sugars as potential carriers for dry powder inhalations. Int J Pharm. 2004;270:297-306. doi:10.1016/j.ijpharm.2003. 10.039. (Pubitemid 38077109)
26. New R R C. Liposomes a practical approach. New York: Oxford University Press; 1990.
27. Brandl M, Bachmann D, Drechsler M, Bauer KH. Liposome preparation by a new high pressure homogenizer gaulin micron Lab 40. Drug Dev Ind Pharm. 1990;16:2167-91. doi:10.3109/03639049009023648.
28. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem. 1959;234:466-8.
29. Shugar D. Measurement of lysozyme activity and the ultra violet inactivation of lysozyme. Biochim Biophys Acta. 1952;8:302-9.
30. Weiner AL. Liposomes as carriers for polypeptides. Adv Drug Deliv Rev. 1989;3:307-41. doi:10.1016/0169-409X (89) 90026-4.
31. Crowe JH, Crowe LM, Carpenter JF, Rudolph AS, Wistrom CA, Spargo BJ et al. Interactions of sugars with membranes. Biochim Biophys Acta. 1988;947:367-84. doi:10.1016/0304-4157 (88) 90015-9.
32. Hoffmann H. Analytical methods and stability testing of biopharmaceuticals. In: McNally EJ, editor. Protein formulation and delivery. New York: Marcel Dekker; 2000. p. 71-110.
33. Elkordy AA, Forbes RT, Barry BW. Integrity of crystalline lysozyme exceeds that of a spray-dried form. Int J Pharm. 2002;247:79-90. doi:10.1016/S0378-5173 (02) 00379-4.
34. Chougule MB, Padhi BK, Misra A. Nano-liposomal dry powder inhaler of amiloride hydrochloride. J Nanosci Nanotech. 2006;6:3001-9. doi:10.1166/jnn. 2006.405.
35. Nirale NM, Vidhate RD, Nagarsenker MS. Fluticasone propionate liposomes for pulmonary delivery. Indian J Pharm Sci. 2009;71:709-11.
36. Giulieria F, Krafft MP. Tubular microstructures made from nonchiral single-chain fluorinated amphiphiles: Impact of the structure of the hydrophobic chain on the rolling-up of bilayer membrane. J Colloid Interf Sci. 2003;258(2):335-44. doi:10.1016/S0021-9797 (03) 00016-X.
37. Lee S.-C., Lee K.-E., Kim J.-J., Lim S.-H. The effect of cholesterol in the liposome bilayer on the stabilization of incorporated retinol. J Liposome Res. 2005;15:157-66. doi:10.1080/08982100500364131. (Pubitemid 43062264)
38. Demel RA, Kruyff BD. The function of sterols in membranes. Biochim Biophys Acta. 1976;457:109-32. doi:10.1016/0304-4157 (76) 90008-3.
39. van Winden E C A, Zhang W, Crommelin D J A. Effect of freezing rate on the stability of liposomes during freeze-drying and rehydration. Pharm Res. 1997;14(9):1151-60. doi:10.1023/A:1012142520912. (Pubitemid 27432536)
40. Lentz B, Carpenter T, Alford DR. Spontaneous fusion of phosphatidylcholine small unilamellar vesicles in the fluid phase. Biochemistry. 1985;26:5389-97. doi:10.1021/bi00391a026.
41. Gorbenko GP, Ioffe VM, Kinnunen P K J. Binding of lysozyme to phospholipid bilayers: evidence for protein aggregation upon membrane association. Biophys J. 2007;93:140-53. doi:10.1529/biophysj.106.102749. (Pubitemid 47041658)
42. Laridi R, Kheadr EE, Benech R.-O., Vuillemard JC, Lacroix C, Fliss I. Liposome encapsulated nisin Z: optimization, stability and release during milk fermentation. Int Dairy J. 2003;13:325-36. doi:10.1016/S0958-6946 (02) 00194-2.
43. Rodriguez-Nogales JM, Lopez AD. A novel approach to develop β-galactosidase entrapped in liposomes in order to prevent an immediate hydrolysis of lactose in milk. Int Dairy J. 2006;16:354-60. doi:10.1016/j. idairyj.2005.05.007. (Pubitemid 43061184)
44. Sebti T, Amighi K. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Eur J Pharm Biopharm. 2006;63:51-8. doi:10.1016/j.ejpb.2005.11.003.